Short answer
ANAPTYSBIO, INC (ANAB) filed an 8-K current report with the SEC on June 22, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). AnaptysBio subleased approximately 45,057 rentable square feet in San Diego to First Tracks Biotherapeutics for 12 months starting June 15, 2026.
ANAPTYSBIO, INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- AnaptysBio subleased approximately 45,057 rentable square feet in San Diego to First Tracks Biotherapeutics for 12 months starting June 15, 2026
- First Tracks pays rent and additional charges matching AnaptysBio’s obligations under the master lease, supporting occupancy-cost recovery
- First Tracks may terminate with three months’ notice, creating potential residual lease exposure for AnaptysBio
- AnaptysBio remains liable to the master landlord and cannot materially amend or terminate the master lease without First Tracks’ consent
- Sublease may extend until the earlier of April 4, 2028 or 12 months after renewal commencement
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ANAPTYSBIO, INC 8-K filings
Get the next ANAB 8-K as it lands
Follow ANAB for push alerts, or ask the research agent what this filing means.